Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trialHillel Panitch, Brian G. Weinshenker, Gordon Francis et al.|Journal of the Neurological Sciences|2005Cited by 98
Postoperative Acute Kidney Injury After Transcatheter Aortic Valve ReplacementSebastian Ayala, David Li|Current anesthesiology reports|2024Cited by 4